—FANG
— • —
$188.21
P/E
33.21
PEG
—
FCF Yield
—
Rev Growth YoY
+3579.0% YoY
Gross Margin
6869.0%
Health Score
5/10
D/E Ratio
0.39
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, making it impossible to name the company or its industry with certainty. The stock trades at $188.21 per share. With market capitalisation data unavailable, cap-tier classification cannot be determined, though the P/E of 33.21x and Price/Sales of 3.54x suggest a company of meaningful scale relative to its earnings base.
Financial Health
Score: 5/10
The balance sheet carries a conservative Debt/Equity ratio of 0.39x, which is a genuine positive. However, the current ratio of 0.42x is well below the standard 1.0x threshold, meaning the company's short-term liabilities materially exceed its short-term assets — a meaningful liquidity concern...
Risk Assessment
- LIQUIDITY: Current ratio of 0.42x signals that short-term liabilities significantly exceed short-term assets, raising near-term funding risk.
- EARNINGS COLLAPSE: Earnings growth of -6,434% year-over-year directly contradicts the headline revenue surge, suggesting the revenue growth is not translating into profitability.
- DATA TRANSPARENCY: TTM Revenue, TTM Net Income, FCF, market cap, and DCF fair value are all absent, severely limiting fundamental analysis.
- TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates deteriorating price momentum.
- VALUATION PREMIUM WITH UNCERTAINTY: P/E of 33.21x sits 33% above the sector average of 25x, with no PEG or DCF support to validate the growth multiple.
---...
**Score: 5/10** The balance sheet carries a conservative Debt/Equity ratio of 0.39x, which is a genuine positive. However, the current ratio of 0.42x is well below the standard 1.0x threshold, meaning the company's short-term liabilities materially exceed its short-term assets — a meaningful liquidity concern. Free cash flow data is unavailable, which limits any assessment of the company's ability to self-fund operations or return capital to shareholders, and accordingly caps this score. ---
- **LIQUIDITY:** Current ratio of 0.42x signals that short-term liabilities significantly exceed short-term assets, raising near-term funding risk. - **EARNINGS COLLAPSE:** Earnings growth of -6,434% year-over-year directly contradicts the headline revenue surge, suggesting the revenue growth is not translating into profitability. - **DATA TRANSPARENCY:** TTM Revenue, TTM Net Income, FCF, market cap, and DCF fair value are all absent, severely limiting fundamental analysis. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates deteriorating price momentum. - **VALUATION PREMIUM WITH UNCERTAINTY:** P/E of 33.21x sits 33% above the sector average of 25x, with no PEG or DCF support to validate the growth multiple. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives